Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3551 Roger Brooke Dr
Fort Sam Houston, TX 78234Phone+1 210-916-5046Fax+1 215-728-1185
Summary
- Douglas Lee, DO, is a Radiation Oncologist located in Fort Sam Houston, TX, specializing in advanced radiation techniques, including intensity-modulated radiation therapy and stereotactic body radiotherapy. He completed his residency at Temple University Hospital/Fox Chase Cancer Center and has been practicing at Brooke Army Medical Center since 2020. Dr. Lee has contributed to the field through research, authoring papers on subjects such as brachytherapy for prostate cancer and recurrences in head and neck cancer, with several citations in clinical publications.
Education & Training
- Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2016 - 2020
- William Beaumont Army Medical CenterInternship, Transitional Year, 2012 - 2013
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2012
- University of Notre DameBS, Science Business, 2004 - 2008
Certifications & Licensure
- KY State License 2021 - 2026
- PA State License 2018 - 2026
- TX State License 2018 - 2025
- NE State License 2013 - 2024
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 2 citationsComparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer.Peter L Lee, Karen Ruth, Douglas Y Lee, Mark A Hallman, David Y T Chen
Brachytherapy. 2024-07-26 - Imaging defined rapid recurrence is an independent risk factor for worse overall survivalD.Y. Lee, Jesty Abraham, John A. Ridge, Thomas J. Galloway
Head & Neck. 2021-01-25 - 6 citationsRapid recurrence in head and neck cancer: Underappreciated problem with poor outcome.D.Y. Lee, Jesty Abraham, Eric A. Ross, John A. Ridge, Miriam N. Lango
Head & Neck. 2021-01-01
Other Languages
- Chinese (Mandarin), Taiwanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: